Vascular endothelial growth factor improves the therapeutic effects of cyclodextrin in Niemann-Pick type C mice

Min Seock Jeong, Jae sung Bae, Hee Kyung Jin

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Niemann-Pick type C disease (NP-C) is a fatal neurodegenerative disorder caused by a deficiency in the function of the NPC1 gene. Malfunction of this gene/protein leads to progressive accumulation of unesterified cholesterol and sphingolipids in many organs, including the brain. To date, drugs that target pivotal stages in the pathogenic cascade have been tested as monotherapies or in combination with a second agent, showing additive benefits. In this study, we have investigated the effects of combining centrally and systemically administered therapies in a mouse model of NP-C, i.e. overexpression of brain-specific vascular endothelial growth factor (VEGF) in combination with systemic administration of 2-hydroxypropyl-β-cyclodextrin (CD). We found that animals treated using a combination of VEGF and CD showed an improvement in pathophysiology compared to those treated with CD alone or brain VEGF overexpression alone, or non-treated NP-C mice. Combination therapy increased the time period over which NP-C mice maintained their body-weight and motor function, and decreased the abnormal accumulation of lipids. In addition, combination therapy delayed the onset of Purkinje cell loss and reduced neuroinflammation. Taken together, our results demonstrate that combination therapy using VEGF and CD is a promising therapeutic modality for treating NP-C, and suggest that it represents a potential strategy for the treatment of diseases that cause both visceral and brain pathologies.

Original languageEnglish
Pages (from-to)346-354
Number of pages9
JournalAnimal Cells and Systems
Volume23
Issue number5
DOIs
StatePublished - 3 Sep 2019
Externally publishedYes

Keywords

  • 2-hydroxypropyl-β-cyclodextrin
  • Niemann-Pick type C disease mouse
  • combination therapy
  • neuroinflammation
  • vascular endothelial growth factor

Fingerprint

Dive into the research topics of 'Vascular endothelial growth factor improves the therapeutic effects of cyclodextrin in Niemann-Pick type C mice'. Together they form a unique fingerprint.

Cite this